{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:50:10Z","timestamp":1793065810040,"version":"4.5.0"},"reference-count":22,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007378","name":"Associazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Viatris","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"DOI":"10.13039\/501100007458","name":"Deutschen Multiple Sklerose Gesellschaft","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/501100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dutch MS Research Foundation"},{"DOI":"10.13039\/501100002907","name":"Coloplast","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/501100002907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Atlas of MS provides a dataset on multiple sclerosis. This analysis updates the global prevalence (including separate estimates for pediatric multiple sclerosis) and incidence of multiple sclerosis, and examines changes over time using data from 2013, 2020, and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Countries participating in the 2024 Atlas update confirmed or updated epidemiological data. Global prevalence was estimated using submitted case counts supplemented with pooled subregional rates and, for 2020 and 2024, literature-based imputation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Experts in 133 countries representing 93% of the global population participated. Prevalence data were provided by 118 countries. Global multiple sclerosis prevalence per 100,000 rose from 24.8 (95% confidence interval: 24.73\u201324.80) in 2013 to 38.1 (95% confidence interval: 38.09\u201338.17) in 2024 and most regions showed rising prevalence; 3.1 million people now live with multiple sclerosis globally. Higher-income countries reported higher prevalence than lower-income countries. The number of reported pediatric multiple sclerosis cases increased from 7,000 in 2013 to &gt;40,000 in 2024. Incidence data provided by 91 countries estimated that 120,000 new diagnoses occur annually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Global multiple sclerosis prevalence continues to rise. Strengthened and equitable data collection is essential as diagnostic criteria evolve, and these findings provide a benchmark before widespread adoption of the 2024 McDonald criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585261479954","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:45:05Z","timestamp":1788504305000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-788X","authenticated-orcid":false,"given":"Rachel","family":"King","sequence":"first","affiliation":[{"name":"Multiple Sclerosis International Federation (MSIF), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-5595","authenticated-orcid":false,"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada"},{"name":"Departments of Medicine, Nova Scotia Health Authority, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7472","authenticated-orcid":false,"given":"Ingrid","family":"van der Mei","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0556-9720","authenticated-orcid":false,"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-5743","authenticated-orcid":false,"given":"Lydia","family":"Makaroff","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation (MSIF), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-1309","authenticated-orcid":false,"given":"Nick","family":"Rijke","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation (MSIF), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-2347","authenticated-orcid":false,"given":"Anne","family":"Helme","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation (MSIF), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"Walton C King R Rechtman L et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS third edition. Mult Scler 2020; 26(14): 1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","DOI":"10.1177\/1352458520970841"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Palladino R Thompson A Ciccarelli O. Thirty-year trends in multiple sclerosis prevalence lifestyle factors and mortality in England. JAMA Neurol 2026; 83: 503\u2013505. https:\/\/doi.org\/10.1001\/jamaneurol.2026.0352","DOI":"10.1001\/jamaneurol.2026.0352"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Sandesj\u00f6 F Tremlett H Fink K et al. Incidence rate and prevalence of pediatric-onset multiple sclerosis in Sweden: a population-based register study. Eur J Neurol 2024; 31(5): e16253. https:\/\/doi.org\/10.1111\/ene.16253","DOI":"10.1111\/ene.16253"},{"key":"e_1_3_3_5_2","unstructured":"Gilmour H Ramage\u2011Morin PL Wong SL. Multiple sclerosis: prevalence and impact. Health Rep 2018; 29(1): 1\u20138. https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-003-x\/2018001\/article\/54902-eng.htm"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","unstructured":"Wallin MT Culpepper WJ Campbell JD et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology 2019; 92(10): e1029\u2013e1040. https:\/\/doi.org\/10.1212\/WNL.0000000000007035","DOI":"10.1212\/WNL.0000000000007035"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","unstructured":"Solomon AJ Zakaria M Saylor DR et al. Global access to diagnostic paraclinical testing incorporated in the 2024 revised McDonald criteria: disparities and opportunity. Neurol Clin Pract 2026; 16(4): e200633. https:\/\/doi.org\/10.1212\/CPJ.0000000000200633","DOI":"10.1212\/CPJ.0000000000200633"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Solomon AJ Marrie RA Viswanathan S et al. Global barriers to the diagnosis of multiple sclerosis: data from the multiple sclerosis international federation atlas of MS Third Edition. Neurology 2023; 101(6): e624\u2013e635. https:\/\/doi.org\/10.1212\/WNL.0000000000207481","DOI":"10.1212\/WNL.0000000000207481"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Montalban X Lebrun- Fr\u00e9nay C Oh J et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 2025; 24(10): 850\u2013865. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4","DOI":"10.1016\/S1474-4422(25)00270-4"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Gombolay G Johnson L King R et al. Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS Third Edition. J Neurol Neurosurg Psychiatry 2025; 96(8): 814\u2013820. https:\/\/doi.org\/10.1136\/jnnp-2024-335175","DOI":"10.1136\/jnnp-2024-335175"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Koch-Henriksen N Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol 2021; 17(11): 676\u2013688. https:\/\/doi.org\/10.1038\/s41582-021-00556-y","DOI":"10.1038\/s41582-021-00556-y"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Lunde HMB Assmus J Myhr KM et al. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry 2017; 88(8): 621\u2013625. https:\/\/doi.org\/10.1136\/jnnp-2016-315238","DOI":"10.1136\/jnnp-2016-315238"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Campbell JA Simpson-Yap S Taylor BV et al. Significantly increasing multiple sclerosis prevalence in Australia from 2010 to 2021. Mult Scler 2024; 30(9): 1113\u20131127. https:\/\/doi.org\/10.1177\/13524585241265890","DOI":"10.1177\/13524585241265890"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"Azami M YektaKooshali MH Shohani M et al. Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis. PLOS One 2019; 14(4): e0214738. https:\/\/doi.org\/10.1371\/journal.pone.0214738","DOI":"10.1371\/journal.pone.0214738"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","unstructured":"Becker J Pitombeira MS Rojas JI. Epidemiology and characteristics of multiple sclerosis in Latin America. Nat Rev Neurol 2026; 22(1): 22\u201336. https:\/\/doi.org\/10.1038\/s41582-025-01160-0","DOI":"10.1038\/s41582-025-01160-0"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Costa J Massouh J Mrabet S et al. Multiple Sclerosis in the Middle East and North Africa: Perspectives and Challenges. Int J MS Care 2025; 27. https:\/\/doi.org\/10.7224\/1537-2073.2024-086","DOI":"10.7224\/1537-2073.2024-086"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Hwang S Garcia-Dominguez MA Fitzgerald KC et al. Association of Multiple Sclerosis prevalence with sociodemographic health systems and lifestyle factors on a national and regional level. Neurology 2022; 99(16): e1813\u2013e1823. https:\/\/doi.org\/10.1212\/WNL.0000000000200962","DOI":"10.1212\/WNL.0000000000200962"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Simpson SJr Wang W Otahal P et al. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. J Neurol Neurosurg Psychiatry 2019; 90(11): 1193\u20131200. https:\/\/doi.org\/10.1136\/jnnp-2018-320189","DOI":"10.1136\/jnnp-2018-320189"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Krysko KM Graves JS Dobson R et al. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord 2020; 13: 1756286420936166. https:\/\/doi.org\/10.1177\/1756286420936166","DOI":"10.1177\/1756286420936166"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Yeh EA Tremlett H Suntornlohanakul R et al. Access to therapy for children and adolescents with multiple sclerosis: global considerations in preventing disease progression. Lancet Child Adolesc Health 2025; 9(9): 673\u2013684. https:\/\/doi.org\/10.1016\/S2352-4642(25)00133-6","DOI":"10.1016\/S2352-4642(25)00133-6"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"GBD 2016 Multiple Sclerosis Collaborators. Global regional and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(3): 269\u2013285. https:\/\/doi.org\/10.1016\/S1474-4422(18)30443-5","DOI":"10.1016\/S1474-4422(18)30443-5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Brownlee WJ Maccarrone D Nistri R et al. Performance of the 2024 McDonald criteria in patients under evaluation for suspected Multiple Sclerosis. Neurology 2026; 106(6): e214688. https:\/\/doi.org\/10.1212\/WNL.0000000000214688","DOI":"10.1212\/WNL.0000000000214688"},{"key":"e_1_3_3_23_2","unstructured":"Intersectoral global action plan on epilepsy and other neurological disorders. 2022\u20132031: implementation toolkit [Internet] https:\/\/www.who.int\/publications\/i\/item\/9789240096356 (accessed 14 November 2025)."}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585261479954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585261479954","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585261479954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:42:52Z","timestamp":1788666172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585261479954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":22,"alternative-id":["10.1177\/13524585261479954"],"URL":"https:\/\/doi.org\/10.1177\/13524585261479954","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"13524585261479954"}}